As anticipated, distinct doses of SIAIS361034 resulted in no appreciable alterations in the number of platelets, whereas the Bcl-2/Bcl-xL dual inhibitor ABT-263 caused severe thrombocytopenia in mice after 8 h of administration (Figure 7A). This evidence concerns the gene BCL2 and Thrombocytopenia.